CELLUBRIDGE Trademark

Trademark Overview

On Saturday, December 12, 2020, a trademark application was filed for CELLUBRIDGE with the United States Patent and Trademark Office. The USPTO has given the CELLUBRIDGE trademark a serial number of 90377662. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, December 27, 2023. This trademark is owned by Spiderwort Inc.. The CELLUBRIDGE trademark is filed in the Pharmaceutical Products category with the following description:

Neurological implants consisting of biological materials, namely, implants comprising living tissue, cells and pharmacological agents
cellubridge

General Information

Serial Number90377662
Word MarkCELLUBRIDGE
Filing DateSaturday, December 12, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, December 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesNeurological implants consisting of biological materials, namely, implants comprising living tissue, cells and pharmacological agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSpiderwort Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOttawa, Ontario K1Y2C5
CA

Trademark Events

Event DateEvent Description
Wednesday, December 27, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 27, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, December 27, 2023SUSPENSION LETTER WRITTEN
Monday, December 11, 2023DIVISIONAL PROCESSING COMPLETE
Saturday, November 11, 2023DIVISIONAL REQUEST RECEIVED
Monday, December 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 6, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, November 11, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, September 8, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, September 8, 2023INQUIRY TO SUSPENSION E-MAILED
Friday, September 8, 2023SUSPENSION INQUIRY WRITTEN
Friday, March 3, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, March 3, 2023LETTER OF SUSPENSION E-MAILED
Friday, March 3, 2023SUSPENSION LETTER WRITTEN
Wednesday, March 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 1, 2023ASSIGNED TO EXAMINER
Tuesday, February 28, 2023ASSIGNED TO LIE
Monday, December 19, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 13, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, July 13, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, July 13, 2022SUSPENSION INQUIRY WRITTEN
Friday, June 24, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, December 6, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 6, 2021LETTER OF SUSPENSION E-MAILED
Monday, December 6, 2021SUSPENSION LETTER WRITTEN
Saturday, November 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 4, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 4, 2021NON-FINAL ACTION E-MAILED
Friday, June 4, 2021NON-FINAL ACTION WRITTEN
Friday, June 4, 2021ASSIGNED TO EXAMINER
Saturday, February 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 16, 2020NEW APPLICATION ENTERED

Related Keywords

cellubridge implants tissue cells agents living pharmacological namely consisting biological materials